You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

paricalcitol

Showing 1 - 25 of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Pancreatitis Trial in Los Angeles (Paricalcitol, Placebo)

Not yet recruiting
  • Chronic Pancreatitis
  • Paricalcitol
  • Placebo
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 16, 2022

Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)

Active, not recruiting
  • Pancreatic Cancer
  • Boston, Massachusetts
  • +1 more
Jan 9, 2023

Pancreatic Cancer Trial in Philadelphia (Paricalcitol)

Terminated
  • Pancreatic Cancer
  • Paricalcitol
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 29, 2022

Pancreatic Cancer Trial in Philadelphia (Nivolumab, Nab-Paclitaxel, Gemcitabine)

Terminated
  • Pancreatic Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 19, 2022

Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )

Completed
Has Results
  • Pancreatic Cancer
  • +4 more
  • Scottsdale, Arizona
  • +5 more
Dec 1, 2022

Secondary Hyperparathyroidism Trial (Paricalcitol, Placebo)

Not yet recruiting
  • Secondary Hyperparathyroidism
  • Paricalcitol
  • Placebo
  • (no location specified)
Jan 27, 2022

Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Atlanta, Georgia
  • +2 more
Feb 28, 2022

Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7, Stage IA Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Resectable Pancreatic Carcinoma
  • +6 more
  • Gemcitabine Hydrochloride
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 16, 2022

Untreated Metastatic Pancreatic Ductal Adenocarcinoma Trial in Scottsdale (Nivolumab, Albumin-bound paclitaxel, Paricalcitol)

Active, not recruiting
  • Untreated Metastatic Pancreatic Ductal Adenocarcinoma
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 15, 2022

Advanced Pancreatic Cancer Trial in Ireland (Paricalcitol, Gemcitabine (GEM) and Nab-paclitaxel)

Active, not recruiting
  • Advanced Pancreatic Cancer
  • Paricalcitol
  • Gemcitabine (GEM) and Nab-paclitaxel
  • Dublin, Dublin 24, Ireland
  • +5 more
Nov 11, 2021

Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas Trial in Saint Louis (5-FU, Leucovorin, Liposomal Irinotecan)

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 29, 2021

Anemia Trial in Palma de Mallorca (Paricalcitol, Epoetin beta, Placebo)

Recruiting
  • Anemia
  • Paricalcitol
  • +2 more
  • Palma de Mallorca, Islas Baleares, Spain
    Son Espases University Hospital
Mar 3, 2021

Moderate to Severe Secondary Hyperparathyroidism, Stage 5 Chronic Kidney Diseases Trial (Paricalcitol, Darbepoetin alfa)

Completed
Has Results
  • Moderate to Severe Secondary Hyperparathyroidism
  • Stage 5 Chronic Kidney Diseases
  • Paricalcitol
  • Darbepoetin alfa
  • (no location specified)
Jul 28, 2021

Adenocarcinoma of the Pancreas Trial in Philadelphia (Paricalcitol, Abraxane, Gemcitabine)

Completed
  • Adenocarcinoma of the Pancreas
  • Paricalcitol
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 28, 2020

Hypophosphatemia, Familial, Hyperparathyroidism Trial in New Haven (Paricalcitol, Placebo)

Completed
Has Results
  • Hypophosphatemia, Familial
  • Hyperparathyroidism
  • Paricalcitol
  • Placebo
  • New Haven, Connecticut
    Yale University School of Medicine
Mar 3, 2020

Pancreatic Cancer Trial in London (Paclitaxel protein bound, Cisplatin, Gemcitabine)

Unknown status
  • Pancreatic Cancer
  • Paclitaxel protein bound
  • +3 more
  • London, London, Greater, United Kingdom
    Barts Health NHS Trust
Dec 13, 2019

Chronic Kidney Disease Trial in Ponferrada, León (Paricalcitol, Paricalcitol, atorvastatin, Atorvastatin)

Completed
  • Chronic Kidney Disease
  • Paricalcitol
  • +2 more
  • Ponferrada, (León)., Spain
  • +1 more
Aug 22, 2018

Secondary Hyperparathyroidism Due to Renal Causes Trial in Spain (Paricalcitol, Calcifediol)

Completed
Has Results
  • Secondary Hyperparathyroidism Due to Renal Causes
  • Badalona, Barcelona, Spain
  • +15 more
May 18, 2018

Hypersensitivity Trial in Amsterdam (Paricalcitol, Placebo (for paricalcitol))

Completed
  • Hypersensitivity
  • Paricalcitol
  • Placebo (for paricalcitol)
  • Amsterdam, Netherlands
    Academic medical center
Aug 31, 2018

Metastatic Cancer, Prostate Cancer Trial in Winston-Salem (drug, other, procedure)

Terminated
Has Results
  • Metastatic Cancer
  • Prostate Cancer
  • paricalcitol
  • +4 more
  • Winston-Salem, North Carolina
    Wake Forest University Comprehensive Cancer Center
Jul 3, 2018

End-Stage Renal Disease, Secondary Hyperparathyroidism Trial (paricalcitol)

Completed
Has Results
  • End-Stage Renal Disease
  • Secondary Hyperparathyroidism
  • paricalcitol
  • (no location specified)
Jun 1, 2018

Chronic Kidney Disease Stage 3 and 4 Trial (Paricalcitol, Placebo)

Completed
Has Results
  • Chronic Kidney Disease Stage 3 and 4
  • Paricalcitol
  • Placebo
  • (no location specified)
Jun 1, 2018

Mucinous Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer Trial in Winston-Salem (drug, radiation,

Terminated
  • Mucinous Adenocarcinoma of the Rectum
  • +5 more
  • paricalcitol
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jun 29, 2018

Leukemia, MDS Trial in Los Angeles (paricalcitol)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • paricalcitol
  • Los Angeles, California
    Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical
Jan 25, 2018

Disorder of Transplanted Kidney, Proteinuria, Albuminuria Trial in Ljubljana (Paricalcitol, Placebo)

Completed
  • Disorder of Transplanted Kidney
  • +2 more
  • Paricalcitol
  • Placebo
  • Ljubljana, Slovenia
    University Medical Centre Ljubljana
Dec 22, 2017